- Mylan launches generic version of Prandin
- New cholesterol, obesity guidelines give greater role to statins, call for more research into weight-loss drugs
- Study: Pharmavite's CholestOff found to lower LDL
- New guidelines: Half of population between 40 and 75 years old should be on statin regimen
- Walgreens expands preventive healthcare services to Maryland market
PITTSBURGH — Mylan has begun shipping a generic drug for cholesterol, the company said Monday.
Mylan said a subsidiary had started shipping fenofibrate capsules in the 43-mg and 130-mg strengths. The drug is a generic version of Lupin Atlantis Holdings Antara, used in combination with diet to reduce elevated bad cholesterol and other blood lipids and increase beneficial HDL cholesterol in patients with primary hypercholesterolemia or mixed dyslipidemia.
Various versions of the drug had sales of about $60 million during the 12-month period that ended in September 2012, according to IMS Health.